Three biopharmaceutical research companies joined the association as members, while two others transitioned from research associates to full members.
Among the new affiliates is Teva Pharmaceutical Industries. The Israel-based drug company — a generic rival to a majority of the companies that form PhRMA — surprised the pharmaceutical industry when it requested to join the association earlier this month.
The four other new initiates are New Haven, Conn.-based Alexion Pharmaceuticals, Palo Alto, Calif.-based Jazz Pharmaceuticals, Waltham, Mass.-based AMAG Pharmaceuticals, and Lake Forest, Ill.-based Horizon Pharma.
The new members will aid in PhRMA’s efforts to advocate for policy solutions to deliver innovative treatments to patients, modernize the drug development process, promote value-driven healthcare, engage consumers and address market distortions.
More articles on supply chain:
Prince Harry teams up with biotech to raise HIV awareness
CMS, FDA advocate device ID numbers in medical bills and claims
Drugmakers have firm grasp on drug pricing power
